Drawing for ACCENTIA BIOPHARMACEUTICALS

USPTO serial 78498858

ACCENTIA BIOPHARMACEUTICALS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
SHIH, SALLY
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ACCENTIA BIOPHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Biologic product preparations, namely proteins, antibodies, vaccine compositions, antifungals, antitussives, decongestants, cell based products, namely coagulation factors and immune stimulants, and growth factors, namely cytokines, hormones, morphogens and interleukins for use in the diagnosis, cure, mitigation, treatment and prevention of diseases and conditions not associated with diabetes, namely sinus infections, asthma, sinus inflammation, chronic rhinosinusitis, allergic fungal rhinosinusitis, cancers, lymphomas, Non-Hodgkins lymphoma, B-cell Non-Hodgkins lymphoma, diseases of the immune system, tissue repair and tissue growth applications, allergies, cough, cold, inflammation, fever, nausea and vomiting; and pharmaceutical preparations for the treatment and mitigation of painACTIVE
009Scientific devices for the development, production and proliferation of cells and proteins not for use with diabetes associated conditions, namely bioreactors for automated cell culture and protein production; automated protein purification systems comprising filtration cassettes, filtration membranes, filtration modules, columns, chromatography columns, resin packed columns, ion exchange columns, purification monitors, ultraviolet monitors, photometers, valves, tubing, reservoirs, liquid reservoirs, cell culture media reservoirs and collection vessels; cultureware and replacement parts for bioreactors and purification systems including filtration cassettes, filtration membranes, filtration modules, columns, chromatography columns, resin packed columns, ion exchange columns, purification monitors, ultraviolet monitors, photometers, gas exchange cartridges, cell culture cartridges, incubation chambers, pumps, culture chambers, valves, tubing, reservoirs, liquid reservoirs, cell culture media reservoirs and collection vessels; and control systems for use with bioreactors and purification systems namely microprocessors, process control computers, culture monitors, purification monitors, electronic data recorders, ultraviolet monitors and photometersACTIVE
010Drug delivery systems for diseases and conditions not associated with diabetesACTIVE
035Business consultation in the field of commercialization of pharmaceuticals not for use with diabetes associated conditions; distributorship in the field of pharmaceutical products not for use with diabetes associated conditionsACTIVE
042Pharmaceutical drug development services not associated with diabetesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 8, 2009MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 8, 2009ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 11, 2008CORVREVIEW OF CORRESPONDENCE COMPLETE
Dec 11, 2008AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 2, 2008MAILPAPER RECEIVED
Nov 5, 2008EX3GSOU EXTENSION 3 GRANTED
Nov 5, 2008EXT3SOU EXTENSION 3 FILED
Nov 5, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 6, 2008EX2GSOU EXTENSION 2 GRANTED
May 6, 2008EXT2SOU EXTENSION 2 FILED
May 6, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 7, 2007EX1GSOU EXTENSION 1 GRANTED
Nov 7, 2007EXT1SOU EXTENSION 1 FILED
Nov 7, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 23, 2007ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 8, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 13, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 24, 2007NPUBNOTICE OF PUBLICATION
Dec 21, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 21, 2006ALIEASSIGNED TO LIE
Dec 6, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2006XAECEXAMINER'S AMENDMENT ENTERED
Dec 6, 2006GNEAEXAMINERS AMENDMENT E-MAILED
Dec 6, 2006CNEAEXAMINERS AMENDMENT -WRITTEN
Jun 21, 2006GNCFCONTINUATION OF FINAL REFUSAL E-MAILED
Jun 21, 2006CNCFACTION CONTINUING A FINAL - COMPLETED
Jun 8, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 4, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 4, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 14, 2005GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 14, 2005CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 11, 2005ACECAMENDMENT FROM APPLICANT ENTERED
Nov 22, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 22, 2005MAILPAPER RECEIVED
May 17, 2005GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 17, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 16, 2005GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 16, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 16, 2005DOCKASSIGNED TO EXAMINER
Oct 20, 2004NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance